Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Deprivation | 6 | 2014 | 137 | 1.650 |
Why?
|
| Obesity | 6 | 2022 | 963 | 1.060 |
Why?
|
| Insulin Resistance | 3 | 2014 | 377 | 0.790 |
Why?
|
| Energy Intake | 3 | 2022 | 98 | 0.730 |
Why?
|
| Human Growth Hormone | 4 | 2013 | 54 | 0.620 |
Why?
|
| Sleep | 5 | 2013 | 444 | 0.520 |
Why?
|
| Weight Loss | 2 | 2012 | 229 | 0.460 |
Why?
|
| C-Peptide | 1 | 2012 | 174 | 0.420 |
Why?
|
| Ghrelin | 2 | 2022 | 29 | 0.390 |
Why?
|
| Insulin-Secreting Cells | 2 | 2012 | 397 | 0.390 |
Why?
|
| Caloric Restriction | 1 | 2010 | 14 | 0.390 |
Why?
|
| Leptin | 2 | 2022 | 105 | 0.380 |
Why?
|
| Adiposity | 1 | 2010 | 70 | 0.370 |
Why?
|
| Sleep Wake Disorders | 2 | 2010 | 115 | 0.350 |
Why?
|
| Fatigue | 1 | 2010 | 174 | 0.340 |
Why?
|
| Hunger | 2 | 2022 | 23 | 0.320 |
Why?
|
| Blood Glucose | 1 | 2012 | 873 | 0.310 |
Why?
|
| Energy Metabolism | 4 | 2022 | 271 | 0.310 |
Why?
|
| Glucose | 1 | 2009 | 638 | 0.280 |
Why?
|
| Exercise | 1 | 2009 | 315 | 0.280 |
Why?
|
| Cross-Over Studies | 4 | 2013 | 399 | 0.270 |
Why?
|
| Melatonin | 2 | 2023 | 47 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1373 | 0.250 |
Why?
|
| Eating | 3 | 2022 | 166 | 0.240 |
Why?
|
| Quality of Life | 2 | 2010 | 1585 | 0.220 |
Why?
|
| Overweight | 1 | 2022 | 118 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 2 | 2013 | 77 | 0.200 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2020 | 9 | 0.190 |
Why?
|
| Glucose Tolerance Test | 2 | 2012 | 228 | 0.190 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2020 | 25 | 0.190 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2020 | 92 | 0.180 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 220 | 0.180 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 180 | 0.170 |
Why?
|
| Thyrotropin | 2 | 2010 | 280 | 0.170 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 240 | 0.160 |
Why?
|
| Circadian Rhythm | 3 | 2023 | 303 | 0.160 |
Why?
|
| Adult | 8 | 2022 | 25648 | 0.150 |
Why?
|
| Appetite | 2 | 2022 | 26 | 0.140 |
Why?
|
| Male | 9 | 2020 | 40965 | 0.120 |
Why?
|
| Sleep, REM | 2 | 2012 | 50 | 0.120 |
Why?
|
| Wakefulness | 2 | 2012 | 134 | 0.120 |
Why?
|
| Weight Gain | 1 | 2014 | 123 | 0.120 |
Why?
|
| Female | 9 | 2020 | 44532 | 0.120 |
Why?
|
| Hypopituitarism | 1 | 2013 | 19 | 0.110 |
Why?
|
| Humans | 14 | 2023 | 86643 | 0.110 |
Why?
|
| Brain Waves | 1 | 2013 | 32 | 0.110 |
Why?
|
| Diet, Reducing | 1 | 2012 | 31 | 0.110 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2012 | 70 | 0.110 |
Why?
|
| Reference Values | 2 | 2010 | 674 | 0.100 |
Why?
|
| Fasting | 1 | 2012 | 161 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 125 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 269 | 0.090 |
Why?
|
| Sleep Stages | 1 | 2010 | 45 | 0.090 |
Why?
|
| Hormones | 1 | 2010 | 141 | 0.090 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2010 | 147 | 0.090 |
Why?
|
| Luteinizing Hormone | 1 | 2010 | 167 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 131 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 334 | 0.090 |
Why?
|
| Catecholamines | 1 | 2009 | 88 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 584 | 0.080 |
Why?
|
| Thyroxine | 1 | 2010 | 344 | 0.080 |
Why?
|
| Body Composition | 1 | 2008 | 68 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 409 | 0.080 |
Why?
|
| Hydrocortisone | 1 | 2009 | 298 | 0.080 |
Why?
|
| Body Weight | 1 | 2008 | 459 | 0.080 |
Why?
|
| Neurosecretory Systems | 1 | 2007 | 35 | 0.070 |
Why?
|
| Middle Aged | 5 | 2020 | 25028 | 0.070 |
Why?
|
| Critical Illness | 2 | 2023 | 294 | 0.070 |
Why?
|
| Risk Factors | 2 | 2014 | 5417 | 0.070 |
Why?
|
| Time Factors | 2 | 2012 | 5210 | 0.060 |
Why?
|
| Tyrosine | 1 | 2022 | 133 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 125 | 0.050 |
Why?
|
| Polysomnography | 2 | 2013 | 151 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 79 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 301 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2023 | 8489 | 0.040 |
Why?
|
| Biomarkers | 1 | 2023 | 1718 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 18415 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 153 | 0.030 |
Why?
|
| Lighting | 1 | 2012 | 32 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 50 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2012 | 478 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6509 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2012 | 373 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 1139 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2004 | 117 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7993 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 806 | 0.010 |
Why?
|